Trial Profile
Randomized, Double-Blinded, Placebo-Controlled Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Apr 2017
Price :
$35
*
At a glance
- Drugs BMS 986141 (Primary)
- Indications Unspecified
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 26 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 01 Sep 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Aug 2015 to 1 Sep 2015.
- 01 Sep 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Aug 2015 to 1 Sep 2015.